Discrepancies Between Research Advertisements and Disclosure of Study Locations in Trial Registrations for USA-Sponsored Research in Russia
Journal of medical ethics 2010 Jul; 36(7): 431-4
The full disclosure of all locations at which research is conducted is an important requirement of clinical trial registration. Yet, little is known about how well researchers and sponsors disclose this information in their registrations. The aim of this study is to examine the adequacy of study location disclosure on http://ClinicalTrials.gov/ for recent USA-sponsored research in the Russian Federation.
Showing items related by title, author, creator and subject.
McHenry, Leemon B.; Jureidini, Jon N. (2008-07)In this case study from litigation, we show how ghostwriting of clinical trial results can contribute to the manipulation of data to favor the study medication. Study 329 for paroxetine pediatric use was negative for ...
Legal and Ethical Obligations to Conduct a Clinical Drug Trial in Australia as an Investigator Initiated and Sponsored Study for an Overseas Pharmaceutical Company Beran, Roy G. (2004)Most multi-centre trials are both financed and sponsored by the pharmaceutical company involved. What follows will map the path adopted for an investigator initiated and sponsored study for a new indication of an established ...